UGT3A2 anticorps (AA 23-300)
Aperçu rapide pour UGT3A2 anticorps (AA 23-300) (ABIN6149905)
Antigène
Voir toutes UGT3A2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 23-300
-
Séquence
- AKILTISTVG GSHYLLMDRV SQILQDHGHN VTMLNHKRGP FMPDFKKEEK SYQVISWLAP EDHQREFKKS FDFFLEETLG GRGKFENLLN VLEYLALQCS HFLNRKDIMD SLKNENFDMV IVETFDYCPF LIAEKLGKPF VAILSTSFGS LEFGLPIPLS YVPVFRSLLT DHMDFWGRVK NFLMFFSFCR RQQHMQSTFD NTIKEHFTEG SRPVLSHLLL KAELWFINSD FAFDFARPLL PNTVYVGGLM EKPIKPVPQD LENFIAKFGD SGFVLVTL
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 23-300 of human UGT3A2 (NP_777574.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Commentaires
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- UGT3A2 (UDP Glycosyltransferase 3 Family, Polypeptide A2 (UGT3A2))
-
Autre désignation
- UGT3A2
-
Sujet
- UDP-glucuronosyltransferases catalyze phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase water solubility and enhance excretion. They are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds (By similarity.,UGT3A2,Cancer,Signal Transduction,Endocrine & Metabolism,Drug metabolism,UGT3A2
-
Poids moléculaire
- 55 kDa/59 kDa
-
ID gène
- 167127
-
UniProt
- Q3SY77
Antigène
-